Nanonization strategies for poorly water-soluble drugs

Huabing Chen, Chalermchai Khemtong, Xiangliang Yang, Xueling Chang, Jinming Gao

Research output: Contribution to journalArticle

371 Citations (Scopus)

Abstract

Poor water solubility for many drugs and drug candidates remains a major obstacle to their development and clinical application. Conventional formulations to improve solubility suffer from low bioavailability and poor pharmacokinetics, with some carriers rendering systemic toxicities (e.g. Cremophor® EL). In this review, several major nanonization techniques that seek to overcome these limitations for drug solubilization are presented. Strategies including drug nanocrystals, nanoemulsions and polymeric micelles are reviewed. Finally, perspectives on existing challenges and future opportunities are highlighted.

Original languageEnglish (US)
Pages (from-to)354-360
Number of pages7
JournalDrug Discovery Today
Volume16
Issue number7-8
DOIs
StatePublished - Apr 2011

Fingerprint

Water
Pharmaceutical Preparations
Solubility
Micelles
Nanoparticles
Biological Availability
Pharmacokinetics
cremophor EL

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology

Cite this

Nanonization strategies for poorly water-soluble drugs. / Chen, Huabing; Khemtong, Chalermchai; Yang, Xiangliang; Chang, Xueling; Gao, Jinming.

In: Drug Discovery Today, Vol. 16, No. 7-8, 04.2011, p. 354-360.

Research output: Contribution to journalArticle

Chen, Huabing ; Khemtong, Chalermchai ; Yang, Xiangliang ; Chang, Xueling ; Gao, Jinming. / Nanonization strategies for poorly water-soluble drugs. In: Drug Discovery Today. 2011 ; Vol. 16, No. 7-8. pp. 354-360.
@article{7fc771515a494c55a4201af291b7a74a,
title = "Nanonization strategies for poorly water-soluble drugs",
abstract = "Poor water solubility for many drugs and drug candidates remains a major obstacle to their development and clinical application. Conventional formulations to improve solubility suffer from low bioavailability and poor pharmacokinetics, with some carriers rendering systemic toxicities (e.g. Cremophor{\circledR} EL). In this review, several major nanonization techniques that seek to overcome these limitations for drug solubilization are presented. Strategies including drug nanocrystals, nanoemulsions and polymeric micelles are reviewed. Finally, perspectives on existing challenges and future opportunities are highlighted.",
author = "Huabing Chen and Chalermchai Khemtong and Xiangliang Yang and Xueling Chang and Jinming Gao",
year = "2011",
month = "4",
doi = "10.1016/j.drudis.2010.02.009",
language = "English (US)",
volume = "16",
pages = "354--360",
journal = "Drug Discovery Today",
issn = "1359-6446",
publisher = "Elsevier Limited",
number = "7-8",

}

TY - JOUR

T1 - Nanonization strategies for poorly water-soluble drugs

AU - Chen, Huabing

AU - Khemtong, Chalermchai

AU - Yang, Xiangliang

AU - Chang, Xueling

AU - Gao, Jinming

PY - 2011/4

Y1 - 2011/4

N2 - Poor water solubility for many drugs and drug candidates remains a major obstacle to their development and clinical application. Conventional formulations to improve solubility suffer from low bioavailability and poor pharmacokinetics, with some carriers rendering systemic toxicities (e.g. Cremophor® EL). In this review, several major nanonization techniques that seek to overcome these limitations for drug solubilization are presented. Strategies including drug nanocrystals, nanoemulsions and polymeric micelles are reviewed. Finally, perspectives on existing challenges and future opportunities are highlighted.

AB - Poor water solubility for many drugs and drug candidates remains a major obstacle to their development and clinical application. Conventional formulations to improve solubility suffer from low bioavailability and poor pharmacokinetics, with some carriers rendering systemic toxicities (e.g. Cremophor® EL). In this review, several major nanonization techniques that seek to overcome these limitations for drug solubilization are presented. Strategies including drug nanocrystals, nanoemulsions and polymeric micelles are reviewed. Finally, perspectives on existing challenges and future opportunities are highlighted.

UR - http://www.scopus.com/inward/record.url?scp=79953685905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953685905&partnerID=8YFLogxK

U2 - 10.1016/j.drudis.2010.02.009

DO - 10.1016/j.drudis.2010.02.009

M3 - Article

C2 - 20206289

AN - SCOPUS:79953685905

VL - 16

SP - 354

EP - 360

JO - Drug Discovery Today

JF - Drug Discovery Today

SN - 1359-6446

IS - 7-8

ER -